BridgeBio is significantly boosted its development of an novel therapy for cardiac amyloidosis, utilizing Attruby. Preliminary clinical results reveals potential improvements for individuals affected by the debilitating condition. The emphasis highlights researchers’ commitment to addressing critical medical requirements in a heart disease field… Read More